ArticleBioData mining2025
MoRFs_TransFuse: a MoRFs predictor based on multimodal feature fusion and the lightweight Transformer network.
Article in BioData mining, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Molecular recognition features (MoRFs) can facilitate specific protein-protein interactions by undergoing disorder-to-order transitions when binding to their protein partners. Thus, it is essential to accurately predict MoRFs. In this paper, we propose an innovative MoRFs prediction method, named MoRFs_TransFuse, based on multimodal feature fusion and a lightweight Transformer network. To construct high-quality biological features, MoRFs_TransFuse innovatively integrates physicochemical properties, evolutionary features, and pre-trained model embeddings, while retaining optimal feature combinations through multi-window extraction and Random Forest secondary screening. In terms of architecture, MoRFs_TransFuse overcomes the limitations of modeling long-range dependencies by using a self-attention mechanism to accurately capture long-range residue associations in protein sequences. Comparative experiments on benchmark datasets show that MoRFs_TransFuse significantly outperforms existing single component and combined component predictors. Additionally, the lightweight design greatly improves computational efficiency while ensuring prediction accuracy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.